Vortex Energy Corp. Announces Extension of Marketing Program
VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce, further to its news release on July 24, 2026, that it has extended its engagement of MCS Market Communication Service GmbH (“MCS”) (address: Rheinpromenade 13, 0789 Monheim am Rhein; email: info@mcsmarket.de) to provide marketing services for an expected term of 45 days, commencing Oct 19, 2026, provided that the term of the marketing services may be extended or shortened at the discretion of management depending on, amongst other things, the efficiency of the marketing services.
Covered in this story
What has happened since
- Vertex Pharmaceuticals is down 0.3% since this was published, 4 days ago.
- The Marcus Corp is down 0.1% since this was published, 4 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Vertex Pharmaceuticals
- UBS: $528 → $615 by Sep 2027 · Buy via Investing.com
- H.C. Wainwright: $515 → $641 by Sep 2027 · Buy via Investing.com
- BMO Capital Markets: $515 → $600 by Sep 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VRTX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Vertex Pharmaceuticals →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.